Selected research
Industry Research
Fingolimod Industry Research Report 2026
Market perspective
The global Fingolimod market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Fingolimod is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Fingolimod is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Fingolimod is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Fingolimod include Novartis, AstraZeneca, Pharmacor, PharmaCompass, Gilenya, Dr. Reddy's Laboratories, BNF - NICE and Arrow, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Fingolimod market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Fingolimod Market by Company
Novartis
AstraZeneca
Pharmacor
PharmaCompass
Gilenya
Dr. Reddy's Laboratories
BNF - NICE
Arrow
Fingolimod Segment by Type
Oral
Injection
Fingolimod Segment by Application
Medical Field
Science Research Field
Other Fields
Fingolimod Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fingolimod market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fingolimod and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fingolimod.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Fingolimod manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Fingolimod by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Fingolimod in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injection
Applications
- Medical Field
- Science Research Field
- Other Fields
Companies covered
- Novartis
- AstraZeneca
- Pharmacor
- PharmaCompass
- Gilenya
- Dr. Reddy's Laboratories
- BNF - NICE
- Arrow
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Fingolimod Market Size (2021-2032)
- 2.2.2 Global Fingolimod Sales (2021-2032)
- 2.2.3 Global Fingolimod Market Average Price (2021-2032)
- 2.3 Fingolimod by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral
- 2.3.3 Injection
- 2.4 Fingolimod by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Medical Field
- 2.4.3 Science Research Field
- 2.4.4 Other Fields
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Fingolimod Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Fingolimod Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Fingolimod Revenue of Manufacturers (2021-2026)
- 3.4 Global Fingolimod Average Price by Manufacturers (2021-2026)
- 3.5 Global Fingolimod Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Fingolimod, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Fingolimod, Product Type & Application
- 3.8 Global Manufacturers of Fingolimod, Established Date
- 3.9 Global Fingolimod Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis
- 4.1.1 Novartis Company Information
- 4.1.2 Novartis Business Overview
- 4.1.3 Novartis Fingolimod Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis Fingolimod Product Portfolio
- 4.1.5 Novartis Recent Developments
- 4.2 AstraZeneca
- 4.2.1 AstraZeneca Company Information
- 4.2.2 AstraZeneca Business Overview
- 4.2.3 AstraZeneca Fingolimod Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 AstraZeneca Fingolimod Product Portfolio
- 4.2.5 AstraZeneca Recent Developments
- 4.3 Pharmacor
- 4.3.1 Pharmacor Company Information
- 4.3.2 Pharmacor Business Overview
- 4.3.3 Pharmacor Fingolimod Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pharmacor Fingolimod Product Portfolio
- 4.3.5 Pharmacor Recent Developments
- 4.4 PharmaCompass
- 4.4.1 PharmaCompass Company Information
- 4.4.2 PharmaCompass Business Overview
- 4.4.3 PharmaCompass Fingolimod Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 PharmaCompass Fingolimod Product Portfolio
- 4.4.5 PharmaCompass Recent Developments
- 4.5 Gilenya
- 4.5.1 Gilenya Company Information
- 4.5.2 Gilenya Business Overview
- 4.5.3 Gilenya Fingolimod Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Gilenya Fingolimod Product Portfolio
- 4.5.5 Gilenya Recent Developments
- 4.6 Dr. Reddy's Laboratories
- 4.6.1 Dr. Reddy's Laboratories Company Information
- 4.6.2 Dr. Reddy's Laboratories Business Overview
- 4.6.3 Dr. Reddy's Laboratories Fingolimod Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Dr. Reddy's Laboratories Fingolimod Product Portfolio
- 4.6.5 Dr. Reddy's Laboratories Recent Developments
- 4.7 BNF - NICE
- 4.7.1 BNF - NICE Company Information
- 4.7.2 BNF - NICE Business Overview
- 4.7.3 BNF - NICE Fingolimod Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 BNF - NICE Fingolimod Product Portfolio
- 4.7.5 BNF - NICE Recent Developments
- 4.8 Arrow
- 4.8.1 Arrow Company Information
- 4.8.2 Arrow Business Overview
- 4.8.3 Arrow Fingolimod Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Arrow Fingolimod Product Portfolio
- 4.8.5 Arrow Recent Developments
5 Global Fingolimod Market Scenario by Region
- 5.1 Global Fingolimod Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Fingolimod Sales by Region: 2021-2032
- 5.2.1 Global Fingolimod Sales by Region: 2021-2026
- 5.2.2 Global Fingolimod Sales by Region: 2027-2032
- 5.3 Global Fingolimod Revenue by Region: 2021-2032
- 5.3.1 Global Fingolimod Revenue by Region: 2021-2026
- 5.3.2 Global Fingolimod Revenue by Region: 2027-2032
- 5.4 North America Fingolimod Market Facts & Figures by Country
- 5.4.1 North America Fingolimod Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Fingolimod Sales by Country (2021-2032)
- 5.4.3 North America Fingolimod Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Fingolimod Market Facts & Figures by Country
- 5.5.1 Europe Fingolimod Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Fingolimod Sales by Country (2021-2032)
- 5.5.3 Europe Fingolimod Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Fingolimod Market Facts & Figures by Country
- 5.6.1 Asia Pacific Fingolimod Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Fingolimod Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Fingolimod Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Fingolimod Market Facts & Figures by Country
- 5.7.1 South America Fingolimod Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Fingolimod Sales by Country (2021-2032)
- 5.7.3 South America Fingolimod Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Fingolimod Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Fingolimod Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Fingolimod Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Fingolimod Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Fingolimod Sales by Type (2021-2032)
- 6.1.1 Global Fingolimod Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Fingolimod Sales Market Share by Type (2021-2032)
- 6.2 Global Fingolimod Revenue by Type (2021-2032)
- 6.2.1 Global Fingolimod Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Fingolimod Revenue Market Share by Type (2021-2032)
- 6.3 Global Fingolimod Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Fingolimod Sales by Application (2021-2032)
- 7.1.1 Global Fingolimod Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Fingolimod Sales Market Share by Application (2021-2032)
- 7.2 Global Fingolimod Revenue by Application (2021-2032)
- 7.2.1 Global Fingolimod Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Fingolimod Revenue Market Share by Application (2021-2032)
- 7.3 Global Fingolimod Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Fingolimod Value Chain Analysis
- 8.1.1 Fingolimod Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Fingolimod Production Mode & Process
- 8.2 Fingolimod Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Fingolimod Distributors
- 8.2.3 Fingolimod Customers
9 Global Fingolimod Analyzing Market Dynamics
- 9.1 Fingolimod Industry Trends
- 9.2 Fingolimod Industry Drivers
- 9.3 Fingolimod Industry Opportunities and Challenges
- 9.4 Fingolimod Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst